The Effect of Topical Nifedipine in Treatment of Chronic Anal Fissure
,
Abstract
Chronic anal fissure is the most common cause of anal pain associated with internal anal sphincter hypertonia. Reduction of hypertonocity is a special treatment for fissure healing. For this purpose chronic anal fissures were conventionally treated by anal dilatation or by lateral sphincterotomy. However, both of these methods may cause a degree of incontinence in some patients. The uptake of medical therapies that create a reversible chemical sphincterotomy has recently become widespread. The aim of this prospective clinical trial study was to assess the effectiveness of nifedipine in healing anal fissure, a calcium channel blocker that reduces sphincter pressure. A single-blind randomized comparative trial was setup to compare traditional treatment with stool softeners and 2% lidocaine cream against 0.5% nifedipine cream for 4 weeks. 110 patients were included in this study, 60 patients in the nifedipine group and 50 patients in the control group and the therapeutic outcome and side effects were recorded. Healing had occurred in 70% of patients in the nifedipine group and in 12% of patients in the control group after 4 weeks treatment (P < 0.005). Recurrence of symptoms occurred in four of healed patients in the nifedipine group and three patients in the control group in two months. The final result of nifedipine application after 12 months follow up was recurrence in 11 patients (26.19%). Mild headache occurred in four patients (6.6%) of the nifedipine group. Patients in the nifedipine group showed significant healing and relief from pain compared with patients in the control group. Recurrence rate with nifedipine use in spite of control of predisposing factors such as constipation was significant. Another finding was low complication rate with this treatment.
Jonas M, Scholefield JH. Anal Fissure. Gastroenterol Clin North Am 2001;30(1):167-81.
Brown CJ, Dubreuil D, Santoro L, Liu M, O'Connor BI, McLeod RS. Lateral internal sphincterotomy is superior to topical nitroglycerin for healing chronic anal fissure and does not compromise long-term fecal continence: six-year follow-up of a multicenter, randomized, controlled trial. Dis Colon Rectum 2007;50(4):442-8.
Nyam DC, Pemberton JH. Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to incidence of fecal incontinence. Dis Colon Rectum 1999;42(10):1306-10.
Khubchandani IT, Reed JF. Sequelae of internal sphincterotomy for chronic fissure in ano. Br J Surg 1989;76(5):431-4.
Pernikoff BJ, Eisenstat TE, Rubin RJ, Oliver GC, Salvati EP. Reappraisal of partial lateral internal sphincterotomy. Dis Colon Rectum 1994;37(12):1291-5.
Minguez M, Melo F, Espi A, Garcia-Granero E, Mora F, Lledo S, et al. Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum 1999;42(8):1016-21.
Lund JN, Scholefield JH. Glyceryl trinitrate is an effective treatment for anal fissure. Dis Colon Rectum 1997;40(4):468-70.
Bacher H, Mischinger HJ, Werkgartner G, Cerwenka H, El-Shabrawi A, Pfeifer J, Schweiger W. Local nitroglycerin for treatment of anal fissures: an alternative to lateral sphincterotomy? Dis Colon Rectum 1997;40(7):840-5.
Carapeti EA, Kamm MA, Phillips RK. Topical diltiazem and bethanechol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000;43(10):1359-62.
Knight JS, Birks M, Farouk R. Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg 2001;88(4):553-6.
Pitt J, Dawson PM, Hallan RI, Boulos PB. A double-blind randomized placebo-controlled trial of oral indoramin to treat chronic anal fissure. Colorectal Dis 2001;3(3):165-8.
Antropoli C, Perrotti P, Rubino M, Martino A, De Stefano G, Migliore G, et al. Nifedipine for local use in conservative treatment of anal fissures: preliminary resultsof a multicenter study. Dis Colon Rectum 1999;42(8):1011-5.
Perrotti P, Bove A, Antropoli C, Molino D, Antropoli M, Balzano A, et al. Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic analfissure: results of a prospective, randomized, double-blindstudy. Dis Colon Rectum 2002;45(11):1468-75.
Ho KS, Ho YH. Randomized clinical trial comparing oral nifedipine with lateral anal sphincterotomy and tailored sphincterotomy in the treatment of chronic anal fissure. Br J Surg 2005;92(4):403-8.
Lund JN, Scholefield JH. Internal Sphincter Spasm in Anal fissure. Br J Surg 1997;84(12):1723-4.
16.O'Kelly TJ. Nerves that say NO: a new perspective on the human rectoanal inhibitory reflex. Ann R Coll Surg Engl 1996;78(1):31-8.
Lund JN, Scholefield JH. A Randomized, prospective double-blind placebo-controlled trial of Glyceryl trinitrate ointment in the treatment of anal fissure. Lancet1997;349(9044):11-4.
Scholefield JH, Bock JU, Marla B, Richter HJ, Athanasiadis S, Pröls M, et al. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment inpatients with chronic anal fissures. Gut 2003;52(2):264-9.
Kennedy ML, Sowter S, Nguyen H, Lubowski DZ. Glyceryl trinitrate ointment for the treatment of chronic anal fissure: results of a placebo-controlled trial and longterm follow-up. Dis Colon Rectum 1999;42(8):1000-6.
Cook TA, Smilgin Humphreys MM, Mortensen NJ. Oral nifedipine reduces resting anal pressure and heals chronic anal fissures. Br J Surg 1999;86:1269-73.
Jonas M, Neal KR, Abercrombie JF, Scholefield JH. A Randomized Trial of oral versus topical diltiazem for chronic anal fissures. Dis Colon Rectum 2001;44(8):1074-8.
Cook TA, Brading AF, Mortensen NJ. Differences in contractile properties of anorectal smooth muscle and theeffects of calcium channel blockade. Br J Surg 1999;86(1):70-5.
Jonard P, Essamri B. Diltiazem and internal anal sphincter. Lancet 1987;1(8535):754.
Cook TA, Brading AF, Mortensen NJ. Effects of Nifedipine on Anorectal smooth muscle in vitro. Dis Colon Rectum 1999;42(6):782-7..
Fleischmann JD, Huntley HN, Shingleton WB, Wentworth DB. Clinical and Immunological response to nifedipine for the treatment of interstitial cystitis. J Urol 1991;146(5):1235-9.
Oshiro H, Kobayashi I, Kim D, Takenaka H, Hobson RW 2nd, Duran WN. L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo. J Vasc Surg 1995;22(6):732-9; discussion 739-41.
Knight JS, Birks M, Farouk R. Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg 2001;88(4):553-6.
Ezri T, Susmallian S. Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Colon Rectum 2003;46(6):805-8.
Katsinelos P, Papaziogas B, Koutelidakis I, Paroutoglou G, Dimiropoulos S, Souparis A, et al. Topical 0.5% nifedipine vs. lateral internal sphincterotomy for the treatment of chronic anal fissure: long-term follow-up. Int J Colorectal Dis 2006;21(2):179-83.
Nash GF, Kapoor K, Saeb-Parsy K, Kunanadam T, Dawson PM. The long-term results of diltiazem treatment for anal fissure. Int J Clin Pract 2006;60(11):1411-3.
| Files | ||
| Issue | Vol 48, No 5 (2010) | |
| Section | Articles | |
| Keywords | ||
| Fissure in Ano nifedipine calcium channel blockers sphincterotomy | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
